Search results

Page results

• Covid-19 variant more transmissible but does not increase disease severity in hospitalised patients

  A study of patients at UCLH and North Middlesex University Hospital published in The Lancet Infectious Diseases suggests that the B.1.17. variant of Covid-19 is not associated with more severe illness and death, but appears to lead to higher virus load.

• Flow-diverting stents (in the treatment of intracranial aneurysms)

  The aim of this page is to provide you with information about flow-diverting stents and how they are used to treat cerebral (brain) aneurysms.

• How to make a donation

  Information about making a donation to the Haematology Cancer Care charity fund at UCLH

• Cystic fibrosis drug tested to fight inflammation in COVID-19

  Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.

• Rare cases of blood clots and low platelets after vaccination

  UCLH-led research paper outlines mechanism behind rare cases of blood clots and low platelets after vaccination

• UCL, UCLH and Formula One develop life-saving breathing aids for the NHS

  A breathing aid that can help keep Covid-19 patients out of intensive care, adapted by mechanical engineers at UCL and clinicians at UCLH working with Mercedes-AMG High Performance Powertrains (Mercedes-AMG HPP), has been approved for use in the NHS.

• MENO.pause app launched to help clinicians manage patients’ menopause symptoms

  Doctors at UCLH and University College London (UCL) have developed a digital decision-making aid, MENO.pause, to help clinicians manage menopause symptoms in the best way for individual patients’ health conditions.

• Next-generation treatment for multiple myeloma shows early promise

  Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.

• Research into restoring loss of smell and taste in COVID patients

  Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.

• One year at the Royal National ENT and Eastman Dental Hospitals

  The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.